IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence
Stocks in this Quantisnow insightHealth Care
Historical context for IDXX
Across the 20 sessions after earlier IDXX headlines, the stock closed higher 12 times and lower 8 times, with a median move of 0.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | IDXX | SPY |
|---|---|---|---|
| Aug 31, 2026 | IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference | +0.3% | -0.3% |
| Aug 11, 2026 | IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test | -1.5% | -0.3% |
| Aug 4, 2026 | IDEXX Laboratories Announces Second Quarter Results | +3.6% | +1.8% |
| Jul 28, 2026 | IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals | +2.4% | +0.2% |
| Jul 2, 2026 | IDEXX Laboratories to Release 2026 Second Quarter Financial Results | +3.8% | -0.1% |
| May 26, 2026 | IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection | -0.4% | +0.7% |
Quantisnow market dataNASDAQ
IDXX
IDEXX Laboratories Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Listed since
- 1991
Get push alerts for IDXX
Full IDXX profile on Quantisnow Follow IDXX and get a push notification the moment its next story breaks.